---
title: "Abbott Laboratories (ABT.US) Q1 2022 Earnings Conference Call"
description: "Abbott Laboratories is dedicated to discovering, developing, manufacturing, and selling a wide and diverse range of healthcare products. It operates through the"
locale: "en"
url: "https://longbridge.com/en/lives/10325"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Abbott Laboratories (ABT.US) Q1 2022 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Abbott Laboratories is dedicated to discovering, developing, manufacturing, and selling a wide and diverse range of healthcare products. It operates through the following segments: Established Pharmaceuticals, Nutritionals, Diagnostics, and Medical Devices. The Established Pharmaceuticals segment refers to the international sales of a range of branded generic pharmaceutical products. The Nutritionals segment caters to global sales of adult and pediatric nutritional products. The Diagnostics segment is a sub-segment of the market for diagnostic systems and tests used in blood banks, hospitals, commercial laboratories and alternative healthcare testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, diabetes care products for diabetic patients, and neurostimulation devices for the treatment of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, Illinois.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.